Alexey Vladimirovich Chernushkin
Chief Investment Officer bei OTCPharm PJSC
Profil
Alexey Vladimirovich Chernushkin is currently the Deputy General Director-Strategy & Investments at OTCPharm PJSC.
Previously, he worked as the Director-Investor Relations & Capital Markets at Kazakhgold Group Ltd.
in 2011, Director-Investor Relations & Capital Markets at Polyus PJSC, Director-Capital Markets & Investor Relations at Polyus Gold International Ltd., and Investor Relations Contact at Pharmstandard PJSC.
Aktive Positionen von Alexey Vladimirovich Chernushkin
Unternehmen | Position | Beginn |
---|---|---|
OTCPharm PJSC
OTCPharm PJSC Pharmaceuticals: MajorHealth Technology OTCPharm PJSC engages in the production, marketing, promotion and wholesaling of pharmaceutical products. Its product portfolio brands include Arbidol, Pentalgin, Complivit, Flucostat, Aphobasolum, Codelac, Amixin, Acipol, Maxicold, Rinostop, Magnelis B6, Noopept, Asvitol, Ascophen-P, Next, Lactazar, Selmevit, Termicon, Lactonorm, Cyclovita, Cynocap, Univit, Nitrocor, Neosmectin, Klarisens, Azitrox, Gastrozol, Mycoderil. The company was founded on December 23, 2013 and is headquartered in Moscow, Russia. | Chief Investment Officer | - |
Ehemalige bekannte Positionen von Alexey Vladimirovich Chernushkin
Unternehmen | Position | Ende |
---|---|---|
Kazakhgold Group Ltd.
Kazakhgold Group Ltd. Precious MetalsNon-Energy Minerals Kazakhgold Group Ltd. is a gold miner in the Republic of Kazakhstan with a broad gold reserves base. It has three principal operating mines which include Aksu, Bestobe and Zholymbet located in northern part of Kazakhstan and it also has development properties in Eastern Kazakhstan and Romania, as well as potential development opportunities in Kyrgyzstan. The company was founded on September 26, 2005 and is headquartered in London, the United Kingdom. | Investor Relations Kontakt | 28.07.2011 |
FARMSTANDART OAO | Investor Relations Kontakt | - |
POLYUS GOLD INTERNATIONAL LTD | Investor Relations Kontakt | - |
POLYUS | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POLYUS | Non-Energy Minerals |
Private Unternehmen | 4 |
---|---|
Kazakhgold Group Ltd.
Kazakhgold Group Ltd. Precious MetalsNon-Energy Minerals Kazakhgold Group Ltd. is a gold miner in the Republic of Kazakhstan with a broad gold reserves base. It has three principal operating mines which include Aksu, Bestobe and Zholymbet located in northern part of Kazakhstan and it also has development properties in Eastern Kazakhstan and Romania, as well as potential development opportunities in Kyrgyzstan. The company was founded on September 26, 2005 and is headquartered in London, the United Kingdom. | Non-Energy Minerals |
Pharmstandard PJSC
Pharmstandard PJSC Pharmaceuticals: MajorHealth Technology Pharmstandard PJSC engages in the production and wholesale distribution of pharmaceutical and medical products. It operates through the Production and Wholesale of Pharmaceutical Products, and Production and Wholesale of Medical Equipment segments. The company was founded on March 23, 2003 and is headquartered in Dologoprudny, Russia. | Health Technology |
Polyus Gold International Ltd.
Polyus Gold International Ltd. Precious MetalsNon-Energy Minerals Polyus Gold International Ltd. operates as an exploration company. The firm engages in the exploration of gold. It engages in the evaluation, extraction, exploration, mining and development of gold properties. The company was founded on September 12, 2007 and is headquartered in St. Helier, the United Kingdom. | Non-Energy Minerals |
OTCPharm PJSC
OTCPharm PJSC Pharmaceuticals: MajorHealth Technology OTCPharm PJSC engages in the production, marketing, promotion and wholesaling of pharmaceutical products. Its product portfolio brands include Arbidol, Pentalgin, Complivit, Flucostat, Aphobasolum, Codelac, Amixin, Acipol, Maxicold, Rinostop, Magnelis B6, Noopept, Asvitol, Ascophen-P, Next, Lactazar, Selmevit, Termicon, Lactonorm, Cyclovita, Cynocap, Univit, Nitrocor, Neosmectin, Klarisens, Azitrox, Gastrozol, Mycoderil. The company was founded on December 23, 2013 and is headquartered in Moscow, Russia. | Health Technology |